Insider filing · TYRA
RA Capital Healthcare Fund LP bought $1.9M of Tyra Biosciences (TYRA)
Executed Jun 9 2025, disclosed Jun 11 2025, 2 days later.
Value, as filed
$1.9M
186,850 sh × $10.19
Executed
Jun 9 2025
the trade date, as filed
Disclosed
Jun 11 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
-5.1%
-10.8% from execution
Over the 21 trading sessions from the disclosed entry session (Jun 11 2025), the stock returned -5.1% (delay-adjusted); from the execution session (Jun 9 2025), -10.8%. Derived: entry at the session's open, exit at the close 20 sessions later.
The filer
RL
RA Capital Healthcare Fund LP
Director
profile →
RA Capital Healthcare Fund LP (Director) filed 1 Form 4 report as a reporting entity in the trailing twelve months (0 purchases, 1 sale), most often in TYRA. The largest single filing was $58.4M of FULC (4,175,139 sh across 3 lots, as filed), executed Dec 8 2025.
The name
TYRA
TYRA
TYRA · 21 filings in 24 months
ticker →
Insider filings, newest first→
View the original filing at www.sec.gov→
Other filings by RA Capital Healthcare Fund LP in TYRA
TYRAPURCHASE
Tyra Biosciences, Inc.
$19.8M1,220,681 sh × $16.25
Exec Nov 8 2024
Filed Nov 13 2024 · 5:30 PM ET